BACKGROUND: Several molecular methods, such as quantitative fluorescence PCR and multiplex ligationdependent probe amplification, currently serve as important adjuncts to traditional karyotyping for the diagnosis of aneuploidy; however, the performance or throughput limitations of these methods hinder their use for routine prenatal diagnosis and populationbased postnatal screening. We developed a novel approach, called "high-resolution melting analysis of segmental duplications," to detect common aneuploidies.
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Aneuploidy, a deviation from the normal number of 46 chromosomes in humans, is associated with substantial morbidity and mortality, particularly in infancy and childhood (1 ) . Detection of aneuploidy has been considered the most common and important aspect of prenatal testing. Postnatal screening of populations for certain sex chromosome aneuploidies, such as Turner syndrome and Klinefelter syndrome, permits early developmental intervention and reproductive counseling (2, 3 ) . Currently, aneuploidy diagnosis is typically performed through karyotyping, which requires an average of 2 weeks. Assays occasionally fail because of culture failure and/or external contamination. These drawbacks reduce the effectiveness of karyotyping for routine testing, particularly for large-scale populationbased detection. Although some of these drawbacks have been partially overcome with fluorescence in situ hybridization (4 ) , this approach is costly, is laborintensive, and requires both intact cells and a high level of expertise.
Several PCR-based molecular methods that have been developed to address these problems can provide results rapidly and eliminate subjectivity from the diagnosis (5 ) . Quantitative fluorescence PCR is the most widely used PCR method, and its clinical usefulness has been assessed in many studies (6 -8 ) . The major drawback of this technique, however, is that informative short tandem repeat polymorphisms found to be optimal in one human population may be ineffective in another (9 ) . Melting curve analysis of single-nucleotide polymorphisms (SNPs) 2 has also been proposed for estimating chromosome numbers in trisomy 21 detection (10 ); however, this approach requires the selection of multiple SNP markers to produce an informative result. Consequently, determining the heterozygosity of various SNPs is necessary for different populations (11 ) . Real-time quantitative PCR (rtPCR), which relies on the direct quantification of chromosomes rather than on polymorphisms (12 ), could be applicable to all populations. This approach is particularly attractive in clinical practice because of its short turnaround time, easy automation, and avoidance of carryover contamination. Unfortunately, because of the use of dual primer sets in a single reaction, even subtly biased amplification of loci on different chromosomes may produce ambiguous results.
To ensure assay precision, an ideal PCR-based molecular method for aneuploidy detection should use a single primer set for maintaining the original ratio between query chromosomes and reference chromosomes during amplification. Furthermore, an ideal method should not depend on short tandem repeat polymorphisms or SNPs, because use of these types of polymorphisms would limit the assay's universality (13 ) . Four methods that fulfill these criteria are multiplex ligation-dependent probe amplification (MLPA) (14 ) , homologous gene quantitative PCR (15 ) , paralogous sequence quantification (16 ) , and MLPA-based rtPCR (MLPA/rtPCR) (13 ); however, some technical issues surrounding the use of these methods remain to be solved. In the case of MLPA, which is being applied to aneuploidy analysis for an increasing number of diseases (17, 18 ) , requires the preparation of long hybridization probes via phage M13 cloning, and the need for capillary electrophoresis for the post-PCR analysis makes the method costly and susceptible to carryover contamination. Similarly, the need to open tubes after amplification in homologous gene quantitative PCR and paralogous sequence quantification makes these methods labor-intensive, time-consuming, and prone to carryover contamination. Although MLPA/rtPCR assay combines the accuracy of MLPA with the simplicity of rtPCR and can detect trisomies 13, 18, and 21 accurately, the assay requires 20 h to perform. Moreover, this method requires a relatively complicated algorithm for data analysis.
To address some of the problems described above, we have assessed the efficacy of high-resolution melting (HRM) analysis (19 ) , which we have adapted for the first time for the detection of aneuploidy. HRM analysis is a powerful technique for the detection of mutations, polymorphisms, and epigenetic differences in samples of double-stranded DNA. We present the performance of a novel approach based on HRM analysis of segmental duplications (SD-HRM), which reliably detects cases of trisomies 13, 18, and 21, as well as 45,X and 47,XXY, while substantially reducing assay complexity, time, and costs, compared with more conventional methods. Moreover, the resolution study indicates that this method can clearly differentiate changes in dosage as small as 1.05-fold.
Materials and Methods

SAMPLES AND DNA EXTRACTION
For this study, we collected 48 samples from patients with trisomy 21 (44 peripheral blood samples and 4 cord blood samples), 10 cord blood samples from patients with trisomy 18, 3 cord blood samples from trisomy 13 patients, 8 peripheral blood samples from 45,X patients, and 14 peripheral blood samples from 47,XXY patients. Peripheral blood samples from 48 unaffected individuals (24 males and 24 females) were also collected for use as unaffected controls. The karyotypes of all samples had previously been validated by full karyotyping, and these data were withheld from the technician who performed the SD-HRM assays. The Research Ethics Committee of Xiamen Maternal and Child Health Hospital approved the study protocol.
Genomic DNA was extracted from 200 L of blood with the QIAamp DNA Mini Kit (Qiagen) according to the manufacturer's protocol. The concentration of extracted genomic DNA was determined by measuring the ultraviolet absorbance at 260 nm with the NanoVue Plus spectrophotometer (GE Healthcare).
PCR AND HRM
PCR amplification and HRM analysis were performed on a LightCycler 480 II thermocycler (Roche Applied Science) within a 20-L reaction containing 1ϫ LightCycler 480 High Resolution Melting Master (Roche), 2.5 mmol/L Mg 2ϩ , and 250 nmol/L of each forward and reverse primer (for primer and amplicon information, see Table 1 in the Data Supplement that accompanies the online version of this article at http://www.clinchem.org/content/vol58/issue6).
The cycling conditions were as follows: 95°C for 10 min, followed by 40 cycles of 95°C for 15 s, 60°C for 15 s, and 72°C for 15 s. High-resolution melting began with denaturation at 95°C for 1 min and renaturation at 40°C for 1 min, followed by melting from 60°C to 95°C at a ramp rate of 0.03°C/s and acquiring fluorescence data at a frequency of 20 readings/°C.
DATA ANALYSIS
High-resolution melting data were analyzed as graphs of fluorescence vs temperature with the aid of Gene Scanning Software (version 1.5.0; Roche). The melting curve analysis comprised 4 steps: (a) Data were normalized by selecting the linear regions of melting curves before and after DNA dissociation; (b) samples were grouped by shifting the temperature axes of the normalized melting curves; (c) the relative signal differences were plotted vs temperature after the samples were clustered into groups with the aid of the selected reference melting curve; and (d) the relative signal difference between groups at a given temperature was analyzed statistically. Statistical analyses were performed with OriginPro 7.5 software (OriginLab Corporation).
Results
PRINCIPLE OF SD-HRM ANALYSIS
Segmental duplications, which are DNA segments of nearly identical sequence, are widespread in the human genome (20, 21 ) . For segmental duplicates that consist of 2 loci located on different chromosomes (Fig. 1A) , duplicate sequences with several internal differences can be amplified simultaneously with a single primer set, allowing for the preservation of the original ratio of the 2 sequences during amplification (Fig. 1B) . After amplification, the PCR products are analyzed by HRM analysis. Theoretically, different ratios produced by similar sequences yield different melting curve patterns that reflect the dosage abnormalities of the corresponding chromosomes (Fig. 2) .
Segmental duplication information in the human genome can be readily acquired from http:// humanparalogy.gs.washington.edu/ or other relevant databases. SNPs and copy number variations (CNVs) in the amplicon regions should be excluded bioinformatically.
After systematic screening, a series of qualified segmental duplicates were selected as targets, and assays for each were designed. Ideally, a single assay would be sufficient to detect a given aneuploidy; however, in view of the potential existence of unexpected SNPs or CNVs, 2 assays (1 per duplicate region on each chromosome) were combined for the analysis of a given aneuploidy. 
DETECTION OF AUTOSOMAL ANEUPLOIDIES
Trisomies 21, 18, and 13 account for the majority of autosomal aneuploidies in prenatal diagnosis. We designed 6 assays (2 for each type of aneuploidy) to evaluate the performance of SD-HRM analysis in rapidly diagnosing such trisomies. We examined DNA samples from trisomy 21 individuals (n ϭ 48), trisomy 18 individuals (n ϭ 10), and trisomy 13 individuals (n ϭ 3) with T21-1/T21-2, T18 -1/T18 -2, and T13-1/T13-2 assays, respectively. Forty-eight unaffected DNA controls were also screened with each assay. For each reaction, 100 ng DNA was used as template.
The SD-HRM results indicated high concordance with those of the karyotype analysis (Fig. 3A) . Most of the trisomy samples and normal controls were distinctly separated from each other and segregated into different groups. Statistical analysis of the relative signal differences, depending on the given temperature, also indicated substantial differences between the affected and control panels (Fig. 3A) . All of the assays attained 100% diagnostic sensitivity and 100% diagnostic specificity except for the T13-2 assay, in which an unaffected sample was falsely grouped (Fig. 3A and Table 1 ).
A single sample produced inconsistent results in the T13-1 and T13-2 assays; however, testing with a third assay (T13-3) determined the sample to be from an unaffected individual (see Fig. 1 in the online Data Supplement).
DETECTION OF SEX CHROMOSOME ANEUPLOIDIES
Along with trisomy 21, sex chromosome aneuploidies account for the majority of aneuploidies in children who survive. Population-based postnatal screening of such aneuploidies is important because timely detection might assist in early developmental intervention and reproductive counseling (2, 3 ) . To detect such aneuploidies, we designed 2 types of assays: XA assays, which we used to indicate the ratio between the X chromosome and a given autosome, and XY assays, which we designed to indicate the ratio between X and Y chromosomes. In theory, common sex chromosome aneuploidies can be identified by combining analyses with these 2 types of assays (Table 2) .
We used this strategy to examine 22 samples (8 for 45,X and 14 for 47,XXY) and 48 unaffected controls (24 males and 24 females) with the XA-1/XA-2 and XY-1/ XY-2 assays (Fig. 3B) . The majority of the samples were categorized into different groups according to their innate chromosome ratios. Similar to the detection of autosomal aneuploidies, all of the assays attained both 100% diagnostic sensitivity and 100% diagnostic specificity, with the exception of a single unaffected individual who was misclassified as 47,XXY with the XY-1 assay (Fig. 3B and Table 1) ; however, the correct genotype for this sample was confirmed with the third assay, XY-3 (see Fig. 1 in the online Data Supplement).
RESOLUTION STUDY OF SD-HRM ANALYSIS
To explore the resolving power of the SD-HRM analysis, we used the T21-1 assay to test different ratios of trisomy 21 DNA samples and unaffected control samples. Fig. 3C shows that samples containing 10% trisomic DNA (corresponding to a 1.05-fold change in chromosome dosage) had melting curve patterns that differed significantly from those of the unaffected controls (P ϭ 0.00898, one-way ANOVA). Samples containing 20% trisomic DNA (corresponding to a 1.1-fold change in chromosome dosage) were completely differentiated from the unaffected samples, with no overlap, indicating that this method could unambiguously detect a change in chromosome dosage as small as 1.1-fold.
Discussion
Our results show that SD-HRM can be used to clearly differentiate common aneuploidies from unaffected controls. Because the melting analysis is conducted in a single step in sealed tubes, SD-HRM assays are less complex, take less time to complete, are less prone to carryover contamination, are not labor-intensive, and cost less than conventional methods. In addition, the SD-HRM analysis is amenable to automation and provides sufficient capacity for high throughput (22 ) , thus meeting the demands of population-based postnatal screening.
Although our previous approach, MLPA/rtPCR, also reliably detects trisomies 13, 18, and 21 (13 ), the differences in the melting curves obtained with SD-HRM analysis are more pronounced than the differences in the quantification cycle, or fluorescence intensity, obtained with MLPA/rtPCR. This feature also explains the higher resolution and higher accuracy of SD-HRM assays. Moreover, control samples used for HRM analysis can be reused repeatedly after amplification, further reducing labor and costs.
HRM analysis has also been applied to confirm CNVs. Previous SNP-based strategies, however, have performed poorly in aneuploidy detection because the changes in the melting curves are too small to distinguish the aneuploidies from normal samples (23, 24 ) . Furthermore, such strategies are also restricted by the heterozygosity frequencies of SNPs. In contrast, segmental duplicates with multiple base variants within a small amplicon enlarge the melting curve differences between aneuploidies and normal samples. Consistent with a previous study (25 ), we Mixed samples containing 10%, 20%, 30%, 40%, and 50% trisomic DNA were prepared by diluting trisomy 21 DNA with unaffected control DNA. The mixed samples (10 ng) were then analyzed with the T21-1 assay. Relative signal differences at 77.7°C were extracted for statistical analysis. The dashed line indicates that there is no overlap between the samples containing 20% trisomy 21 DNA and samples from the unaffected controls. In the statistical analysis, the line within the box denotes the median, the square within the box denotes the mean, and the horizontal borders of each box denote the interval between the 25th and 75th percentiles. The whiskers denote the interval between the fifth and 95th percentiles in (A) and (B), and the minimum and maximum in (C).
Rapid Diagnosis of Aneuploidy by SD-HRM
found that base-substitution differences between pairs of segmental duplications are much more helpful in discriminating aneuploidies than small insertions or deletions. It appears that heteroduplexes form more readily between sequences of the same size than between those of different lengths. This consideration is important for the discrimination range that we have indicated.
Moreover, as we illustrated with clinical samples, when we combined 2 assays to analyze a given chromosome, we could differentiate all of the aneuploidy samples from the unaffected controls ( Fig. 2 and Table 1) . We attribute such high discrimination to the adoption of segmental duplications as detection targets. The design of a single primer set can be based on the regions shared by the target sequence and the reference sequence. This strategy eliminates the amplification bias between the 2 sequences and thus preserves the original ratio of different chromosomes during amplification. Compared with short tandem repeats or SNPs, segmental duplications are relatively less polymorphic in the human genome. Therefore, the adoption of segmental duplications as detection targets will facilitate the application of SD-HRM analysis in different populations.
The SD-HRM method exhibited remarkably high resolution. We could differentiate a dosage change of as little as 1.05-fold (Fig. 3C ). This level of resolution permits aneuploidy analysis in situations involving chromosomal mosaicism and maternal blood contamination. Cell-free fetal DNA constitutes approximately 10% of the plasma DNA in the maternal circulation in early pregnancy (26 ) . Therefore, the high resolution of SD-HRM analysis may be useful for noninvasive prenatal screening with maternal plasma, thereby fulfilling an elusive but sought-after goal of the research community.
We note, however, that although SNPs and CNVs within the target regions are not found in silico, they may occur in some samples because of individual differences. Such occurrences could lead to the misclassification of melting curves and hence to false or ambiguous findings. To confirm this suspicion, we sequenced unaffected samples for which false positive results were produced with the T13-2 and XY-1 assays, and the results revealed the existence of CNVs (see Fig. 2 in the online Data Supplement). As we have shown, however, this problem can be resolved by combining 2 or more assays in the analysis of a given aneuploidy. Different target regions on the same chromosome should be sufficiently distant from each other so as to reduce the chance of being simultaneously affected by the same CNVs. Furthermore, in clinical practice, discrepancies between related assays should be considered as indicators of structural abnormalities; in such cases, full karyotyping, fluorescence in situ hybridization, or array comparative genomic hybridization analysis should be conducted. Also of note is that our method, like most PCR-based technologies, could miss some cases of structural abnormalities, such as balanced translocations. Nevertheless, this drawback would not hinder the wide application of our method, given that trisomies of chromosomes 13, 18, and 21, as well as aneuploidies of chromosomes X and Y, account for up to 99.9% of disease-associated abnormalities (16 ) .
In summary, the SD-HRM method we have described may advance the diagnostic utility of HRM for aneuploidy analysis. The adoption of segmental duplications as targets of amplification with single primer sets ensures the universality and reliability of this approach. 
